Experimental group:compound Huangdai tablet combined with Decitabine / CAG (HAG)

2 trials

Sponsors

The First affiliated Hospital of Zhejiang Chinese Medical University

Conditions

MDS

Early Phase 1

A multicenter clinical study for compound Huangdai tablet combined with Decitabine / CAG (HAG) regimen in the treatment of high risk MDS

Active, not recruitingITMCTR1900002791

The First affiliated Hospital of Zhejiang Chinese Medical UniversityMDS

Start: 2019-12-01Updated: 2023-02-20

A multicenter clinical study for compound Huangdai tablet combined with Decitabine / CAG (HAG) regimen in the treatment of high risk MDS

Active, not recruitingChiCTR1900027826

The First affiliated Hospital of Zhejiang Chinese Medical UniversityMDS

Start: 2019-12-01Updated: 2019-12-10